CEPI is providing $1.6m to establish a proof-of-concept for the aVaxziPen needle-free vaccine delivery platform to eliminate the need for frozen storage.
CEPI is providing $1.6m to establish a proof-of-concept for the aVaxziPen needle-free vaccine delivery platform to eliminate the need for frozen storage.